National Institute of Standards and Technology

Christiana Care Health System’s Gene Editing Institute awarded genomic cancer research grant from BIRD Foundation

Tuesday, January 31, 2017

For its enormous potential to accelerate the development of personalized cancer therapies, the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute has been awarded a grant of $900,000 from the U.S.-Israel Binational Industrial Research and Development (BIRD) Foundation in partnership with the biotechnology company NovellusDx.

[Read More]

Exco InTouch successful completes HIPAA Privacy audit for NIST guidelines

Wednesday, July 20, 2016

Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, has announced that it has successfully undergone and completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology (NIST) guidelines for Health Insurance Portability and Accountability Act (HIPAA), formally completing the independent auditing process for Privacy & Security.

[Read More]

MedImmune, NIST partner to advance development of biological therapies

Monday, February 23, 2015

MedImmune, the global biologics R&D arm of AstraZeneca, and the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) have signed a five-year agreement to jointly support research that will help advance drug discovery and manufacturing. The effort will focus on tools and measurements that will be used in the development and production of biopharmaceuticals, which are drugs and treatments derived from biological, rather than chemical, sources.

[Read More]